ReviewCancer biology & therapy2024

Navigating precision: the crucial role of next-generation sequencing recurrence risk assessment in tailoring adjuvant therapy for hormone receptor-positive, human epidermal growth factor Receptor2-negative early breast cancer.

Ying Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.